Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160

OBJECTIVE: The aim of this study was to assess long-term golimumab therapy in patients with rheumatoid arthritis (RA) who discontinued previous tumour necrosis factor alpha (TNFα) inhibitor(s) for any reason. METHODS: Results through week 24 of this multicentre, randomised, double-blind, placebo-con...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Smolen, Josef S, Kay, Jonathan, Landewé, Robert B M, Matteson, Eric L, Gaylis, Norman, Wollenhaupt, Jurgen, Murphy, Frederick T, Zhou, Yiying, Hsia, Elizabeth C, Doyle, Mittie K
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2012
Assuntos:
Clinical and Epidemiological Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3439650/
https://ncbi.nlm.nih.gov/pubmed/22459542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2011-200956
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados